MedAdvisor Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 67.75 million compared to AUD 38.77 million a year ago. Net loss was AUD 17.35 million compared to AUD 13.95 million a year ago.

Basic loss per share from continuing operations was AUD 0.046 compared to AUD 0.045 a year ago. Diluted loss per share from continuing operations was AUD 0.046 compared to AUD 0.045 a year ago.